Radiodiagnosis Department, Faculty of Medicine, Ain Shams University
10.12816/0040120
Abstract
Aim of work: this study aimed assess the efficacy of radioembolization (Yttrium-90) therapy in Hepatocellular carcinoma (HCC) patients with portal vein thrombosis. Patients and methods: this study included 24 patients diagnosed with HCC and portal vein invasion to be treated with Transarterial Radioembolization (TARE). They were 17 males and 7 females. Patients received a single course of treatment. Results: tumor radiological response assessment revealed that the tumor was controlled in 92% of the patients. Complete response was observed in 21 % of the patients, partial response in 29 % of the patients, stable disease in 42 % of the patients and progressive disease in 8% of the patients. Conclusion: Yttrium-90 radioemblization appeared to be an effective, safe and feasible treatment option for patients with hepatocelluar carcinoma with portal vein invasion.
Hetta, E. A., Abdel Hameed, O. M., & Noreldien, A. H. A. (2017). Radioembolization in Treatment of Hepatocellular Carcinoma with Portal Vein Invasion. The Egyptian Journal of Hospital Medicine, 69(1), 1674-1679. doi: 10.12816/0040120
MLA
Elsahhar Ahmed Hetta; Osama Mohamed Abdel Hameed; Aly Haggag Aly Noreldien. "Radioembolization in Treatment of Hepatocellular Carcinoma with Portal Vein Invasion", The Egyptian Journal of Hospital Medicine, 69, 1, 2017, 1674-1679. doi: 10.12816/0040120
HARVARD
Hetta, E. A., Abdel Hameed, O. M., Noreldien, A. H. A. (2017). 'Radioembolization in Treatment of Hepatocellular Carcinoma with Portal Vein Invasion', The Egyptian Journal of Hospital Medicine, 69(1), pp. 1674-1679. doi: 10.12816/0040120
VANCOUVER
Hetta, E. A., Abdel Hameed, O. M., Noreldien, A. H. A. Radioembolization in Treatment of Hepatocellular Carcinoma with Portal Vein Invasion. The Egyptian Journal of Hospital Medicine, 2017; 69(1): 1674-1679. doi: 10.12816/0040120
)
View on SCiNiTO